Abstract
CYP2C19 is an important member of the cytochrome P-450 enzyme superfamily and plays a significant role in the drug metabolism. In order to gain insights for developing personalized drugs, the structure-activity relationships of two SNPs, W120R and I331V, with the ligands of CEC, Fluvoxamine, Lescol and Ticlopidine were investigated through the structure-activity relationship approach. By means of a series of docking studies, the binding pockets of the two SNPs for the four compounds are explicitly defined that will be very useful for conducting mutagenesis studies, providing insights into personalization of drug treatments and stimulating novel strategies for finding desired personalized drugs.
Keywords: CYP2C19, Cytochrome P-450, Structure-activity relationship, CEC, Fluvoxamine, Lescol, Ticlopidine, Personalized drug design
Protein & Peptide Letters
Title: Molecular Modeling of Two CYP2C19 SNPs and Its Implications for Personalized Drug Design
Volume: 15 Issue: 1
Author(s): Dong-Qing Wei, Jing-Fang Wang, Chao Chen, Yixue Li and Kuo-Chen Chou
Affiliation:
Keywords: CYP2C19, Cytochrome P-450, Structure-activity relationship, CEC, Fluvoxamine, Lescol, Ticlopidine, Personalized drug design
Abstract: CYP2C19 is an important member of the cytochrome P-450 enzyme superfamily and plays a significant role in the drug metabolism. In order to gain insights for developing personalized drugs, the structure-activity relationships of two SNPs, W120R and I331V, with the ligands of CEC, Fluvoxamine, Lescol and Ticlopidine were investigated through the structure-activity relationship approach. By means of a series of docking studies, the binding pockets of the two SNPs for the four compounds are explicitly defined that will be very useful for conducting mutagenesis studies, providing insights into personalization of drug treatments and stimulating novel strategies for finding desired personalized drugs.
Export Options
About this article
Cite this article as:
Wei Dong-Qing, Wang Jing-Fang, Chen Chao, Li Yixue and Chou Kuo-Chen, Molecular Modeling of Two CYP2C19 SNPs and Its Implications for Personalized Drug Design, Protein & Peptide Letters 2008; 15 (1) . https://dx.doi.org/10.2174/092986608783330305
DOI https://dx.doi.org/10.2174/092986608783330305 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Co-Editor
Current Enzyme Inhibition Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Current Pharmaceutical Design In Vitro Antimycobacterial Activity of New 7-Chloroquinoline Derivatives
Letters in Drug Design & Discovery SARS-CoV-2: Molecular Biology and Therapeutic Targets
Coronaviruses Synthesis of Some Benzothiazole Based Piperazine-Dithiocarbamate Derivatives and Evaluation of Their Anticancer Activities
Letters in Drug Design & Discovery SARS-CoV-2: Possible Factors Contributing to Serious Consequences of COVID-19?
New Emirates Medical Journal Electronic-Topological and Neural Network Approaches to the Structure- Antimycobacterial Activity Relationships Study On Hydrazones Derivatives
Medicinal Chemistry Synthesis of Aminoalkoxy Substituted 4,5-Diphenylisoxazole Derivatives as Potential Anti-osteoporotic Agents
Medicinal Chemistry The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases
Current Pharmaceutical Design Clinical and Pre-clinical Applications of the Transcendental Meditation Program® in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults
Current Hypertension Reviews Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators
Current Topics in Medicinal Chemistry Development of Neurochemical Normalization (“Agonist Substitution”) Therapeutics for Stimulant Abuse: Focus on the Dopamine Uptake Inhibitor, GBR12909
Current Medicinal Chemistry - Central Nervous System Agents The Quinolone Family: From Antibacterial to Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Programs to Facilitate Tuberculosis Drug Discovery: The Tuberculosis Antimicrobial Acquisition and Coordinating Facility
Infectious Disorders - Drug Targets Quantification of Glycyrrhetic Acid in Human Plasma by LC–MS/MS: Application to a Pharmacokinetic Study
Current Pharmaceutical Analysis Novel Strategies for the Treatment of Asthma
Recent Patents on Inflammation & Allergy Drug Discovery QSAR and Complex Network Recognition of miRNAs in Stem Cells
Current Bioinformatics Peptide Microarrays: Next Generation Biochips for Detection, Diagnostics and High-Throughput Screening
Current Pharmaceutical Design Quantitative Structure-activity Relationship Study of Betulinic Acid Derivatives Against HIV using SMILES-based Descriptors
Current Computer-Aided Drug Design Aminoquinoline Melanin-Concentrating Hormone 1-Receptor (MCH1-R) Antagonists
Current Topics in Medicinal Chemistry